Correlation between different levels of Her-2 protein expression and the efficacy of neoadjuvant therapy in Her-2 positive breast cancer

Her-2 (3+) expression correlates with superior pCR rates, underscoring the need for further research to refine patient selection for optimized targeted therapy benefits.

Authors

Institutions

Publication Details

Journal
Frontiers in Oncology
Published
2025-11-06
DOI
https://doi.org/10.3389/fonc.2025.1673234
Primary Topic
HER2/EGFR in Cancer Research
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Correlation between different levels of Her-2 protein expression and the efficacy of neoadjuvant therapy in Her-2 positive breast cancer

Zhe Cui, Wenhui Wang, Hongbo Li, Zhiyong Wang et al.
Frontiers in Oncology
HER2/EGFR in Cancer Research
article

Correlation between different levels of Her-2 protein expression and the efficacy of neoadjuvant therapy in Her-2 positive breast cancer

Zhe Cui, Wenhui Wang, Hongbo Li, Zhiyong Wang, Yandong Li
article en

Abstract

Her-2 (3+) expression correlates with superior pCR rates, underscoring the need for further research to refine patient selection for optimized targeted therapy benefits.

Frontiers in OncologyVol. 15
Beihua University (CN), Jinhua Academy of Agricultural Sciences (CN), Jinhua Central Hospital (CN)
People's Government of Jilin Province
Openalex Percentile: Top 55%
HER2/EGFR in Cancer Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Correlation between different levels of Her-2 protein expression and the efficacy of neoadjuvant therapy in Her-2 positive breast cancer — Zhe Cui, Wenhui Wang, et al. · Frontiers in Oncology (2025) | TGRS Research Map | TGRS